Sljedeći

Auto Play

Upfront Immunotherapy for Metastatic Kidney Cancer

0 Pogledi • 06/26/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play